3.00
price down icon3.54%   -0.11
after-market Handel nachbörslich: 3.15 0.15 +5.00%
loading

Kyverna Therapeutics Inc Aktie (KYTX) Neueste Nachrichten

pulisher
11:42 AM

KYTX Deadline: KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Lawsuit - PR Newswire

11:42 AM
pulisher
11:05 AM

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics - PR Newswire

11:05 AM
pulisher
05:45 AM

Kyverna Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Kyverna Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025KYTX - PR Newswire

05:45 AM
pulisher
Feb 06, 2025

The Gross Law Firm Reminds Kyverna Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 7, 2025KYTX - PR Newswire

Feb 06, 2025
pulisher
Feb 06, 2025

Investors in Kyverna Therapeutics, Inc. Should Contact The Gross Law Firm Before February 7, 2025 to Discuss Your Rights – KYTX - GlobeNewswire Inc.

Feb 06, 2025
pulisher
Feb 06, 2025

KYTX DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors - The Bakersfield Californian

Feb 06, 2025
pulisher
Feb 05, 2025

Deadline Soon: Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit - Business Wire

Feb 05, 2025
pulisher
Feb 04, 2025

Kyverna Therapeutics, Inc. Investors: Please contact the - GlobeNewswire

Feb 04, 2025
pulisher
Feb 04, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Kyverna Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesKYTX - PR Newswire

Feb 04, 2025
pulisher
Feb 04, 2025

Class Action Filed Against Kyverna Therapeutics, Inc. - GlobeNewswire

Feb 04, 2025
pulisher
Feb 04, 2025

INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors of - GlobeNewswire

Feb 04, 2025
pulisher
Feb 04, 2025

KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Fraud Lawsuit Filed by the Schall Law Firm - PR Newswire

Feb 04, 2025
pulisher
Feb 04, 2025

KYTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Kyverna Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 04, 2025
pulisher
Feb 04, 2025

Final Deadline for the Kyverna Therapeutics, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsKYTX - PR Newswire

Feb 04, 2025
pulisher
Feb 04, 2025

KYVERNA THERAPEUTICS, INC. (NASDAQ: KYTX) DEADLINE ALERT: - GlobeNewswire

Feb 04, 2025
pulisher
Feb 03, 2025

Lawsuit filed for Investors who lost money with shares of Kyverna Therapeutics, Inc. (NASDAQ: KYTX) - openPR

Feb 03, 2025
pulisher
Feb 03, 2025

Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire

Feb 03, 2025
pulisher
Feb 03, 2025

KYVERNA THERAPEUTICS 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc.KYTX - Business Wire

Feb 03, 2025
pulisher
Feb 03, 2025

KYTX FINAL DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, - GlobeNewswire

Feb 03, 2025
pulisher
Feb 03, 2025

DEADLINE ALERT for BOOM, KYTX, MQ, and SUI: The Law Offices - GlobeNewswire

Feb 03, 2025
pulisher
Feb 03, 2025

KYTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Feb 03, 2025
pulisher
Feb 03, 2025

2025-02-03 | KYTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Kyverna Therapeutics, Inc. to Contact the Firm Today! | NDAQ:KYTX | Press Release - Stockhouse Publishing

Feb 03, 2025
pulisher
Feb 03, 2025

Kyverna Therapeutics, Inc. (NASDAQ:KYTX) Short Interest Up 13.9% in January - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

The Gross Law Firm Notifies Kyverna Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineKYTX - PR Newswire

Feb 03, 2025
pulisher
Feb 03, 2025

Shareholders that lost money on Kyverna Therapeutics, - GlobeNewswire

Feb 03, 2025
pulisher
Feb 02, 2025

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics - GlobeNewswire

Feb 02, 2025
pulisher
Feb 02, 2025

2025-02-02 | KYTX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Kyverna Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:KYTX | Press Release - Stockhouse Publishing

Feb 02, 2025
pulisher
Jan 31, 2025

KYVERNA THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Ky - PR Newswire

Jan 31, 2025
pulisher
Jan 31, 2025

KYTX DEADLINE ALERT: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, - GlobeNewswire

Jan 31, 2025
pulisher
Jan 31, 2025

KYTX Shareholder Reminder: Kessler Topaz Meltzer & Check, - GlobeNewswire

Jan 31, 2025
pulisher
Jan 30, 2025

ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Kyverna Therapeutics - PR Newswire

Jan 30, 2025
pulisher
Jan 30, 2025

Levi & Korsinsky Announces the Filing of a Securities Class - GlobeNewswire

Jan 30, 2025
pulisher
Jan 30, 2025

Deadline Alert: Kyverna Therapeutics, Inc. (KYTX) Investors - GlobeNewswire

Jan 30, 2025
pulisher
Jan 30, 2025

Deadline Alert: Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Urged To Contact Glancy Prongay & - EIN News

Jan 30, 2025
pulisher
Jan 30, 2025

Kyverna Therapeutics, Inc. Sued for Securities Law ViolationsContact The Gross Law Firm Before February 7, 2025 to Discuss Your RightsKYTX - PR Newswire

Jan 30, 2025
pulisher
Jan 30, 2025

KYVERNA THERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire

Jan 30, 2025
pulisher
Jan 29, 2025

Kyverna Therapeutics, Inc. Investors: Please contact the Portnoy Law Firm to recover your ... - The Bakersfield Californian

Jan 29, 2025
pulisher
Jan 28, 2025

KYVERNA THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Kyverna Therapeutics, Inc. - GlobeNewswire Inc.

Jan 28, 2025
pulisher
Jan 28, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kyverna Therapeutics, Inc. Investors to Secure ... - The Hastings Tribune

Jan 28, 2025
pulisher
Jan 28, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Kyverna - GlobeNewswire

Jan 28, 2025
pulisher
Jan 28, 2025

Kyverna Therapeutics, Inc. (KYTX) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - The Eastern Progress Online

Jan 28, 2025
pulisher
Jan 28, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Kyverna Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - Victoria Advocate

Jan 28, 2025
pulisher
Jan 28, 2025

Kyverna Therapeutics, Inc. Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Reminds Kyverna Therapeutics, Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit - Morningstar

Jan 28, 2025
pulisher
Jan 28, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadli - GuruFocus.com

Jan 28, 2025
pulisher
Jan 28, 2025

Kyverna Therapeutics Class Action: How to File a Claim Against the Firm - Lawyer Monthly Magazine

Jan 28, 2025
pulisher
Jan 28, 2025

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 7, 2025 in Kyverna Therapeutics, Inc. LawsuitKYTX - PR Newswire

Jan 28, 2025
pulisher
Jan 27, 2025

KYTX Investors Have Opportunity to Lead Kyverna Therapeutics, Inc. Securities Lawsuit - The Malaysian Reserve

Jan 27, 2025
pulisher
Jan 27, 2025

Kessler Topaz Meltzer & Check, LLP Announces KYTX DEADLINE REMINDER: Important February 7, 2025 Deadline Reminder in Kyverna Therapeutics, Inc. Securities Class Action Lawsuit - Business Wire

Jan 27, 2025
$79.95
price down icon 1.03%
$20.11
price down icon 2.71%
$347.71
price down icon 1.71%
$4.69
price down icon 6.94%
biotechnology ONC
$223.50
price down icon 2.35%
$117.61
price down icon 1.94%
Kapitalisierung:     |  Volumen (24h):